Search
for
Sort by
Research 31–60 of 261
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Recalcitrant lichen planopilaris treated with upadacitinib: a case series
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Upadacitinib for the treatment of alopecia areata – A case report
- 73338 Upadacitinib for the Treatment of Refractory Alopecia Areata in Pediatric Patients: A Retrospective Study
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- 73192 Consistent Efficacy of Upadacitinib in Alopecia Areata Subgroups: Adult, Pediatric, Severe Disease, and JAK-Refractory Patients — A Meta-Analysis
- Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
- 76957 Efficacy and Safety of Upadacitinib in Adolescents and Adults with Severe Alopecia Areata: A Subgroup Analysis of the UP-AA Phase 3 Clinical Program
- 77015 Subgroup Analysis of Efficacy of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata From the UP-AA Phase 3 Program
- Real-world retrospective study with upadacitinib in patients with severe alopecia areata: A series of 23 cases
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- A review of Janus kinase inhibitor use in scarring alopecia
- Medical Dermatology
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition